Ardena caters for all your biomarker research needs. From discovery and screening for novel biomarkers through to the bioanalysis of biomarkers in regulated clinical trials.

With a “fit for purpose” validation strategy, the validation status of your biomarker assay will increase to a higher level alongside the development of your drug compound.

In addition, Ardena is part of the biomarker consortium Biomarker Bay, which provides us with access to a huge knowledge base and capacity.